Literature DB >> 8509434

Molecular and cellular features of esophageal cancer cells.

T Nishihira, Y Hashimoto, M Katayama, S Mori, T Kuroki.   

Abstract

More than 70 cell lines were established from esophageal cancer, including 15 TE-series cell lines established by the authors. This article reviews molecular and cellular features of esophageal cancer cells from studies using these cell lines as well as primary tumors. The subjects reviewed include primary cultures of normal epithelium of the esophagus and of esophageal tumors, their growth and differentiation properties, chromosomal aberrations, protein kinase C, growth factors and their receptors, oncogenes, and tumor-suppressor genes. Lesions of genetic loci in esophageal cancer include the absence of mutations in ras genes in primary tumors, amplification and overexpression of the c-erbB gene, co-amplification of hst-1 and int-2 genes, mutations, and allelic loss of tumor suppressor genes, p53, Rb, APC, and MCC. Future clinical improvement will be achieved on the basis of the understanding of molecular and cellular features of esophageal cancer cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8509434     DOI: 10.1007/BF01215923

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  71 in total

1.  Detection of high incidence of K-ras oncogenes during human colon tumorigenesis.

Authors:  K Forrester; C Almoguera; K Han; W E Grizzle; M Perucho
Journal:  Nature       Date:  1987 May 28-Jun 3       Impact factor: 49.962

2.  Amplification, overexpression, and rearrangement of the erbB-2 protooncogene in primary human stomach carcinomas.

Authors:  J B Park; J S Rhim; S C Park; S W Kimm; M H Kraus
Journal:  Cancer Res       Date:  1989-12-01       Impact factor: 12.701

3.  Protein kinase C activities and bindings of a phorbol ester tumor promoter in 41 cell lines.

Authors:  K Chida; N Kato; S Yamada; T Kuroki
Journal:  Biochem Biophys Res Commun       Date:  1988-11-30       Impact factor: 3.575

4.  A new cell line (TE-3) derived from human squamous cell carcinoma of the esophagus.

Authors:  Y Kuriya; M Kitamura; T Akaishi; K Hirayama; Y Sekine; T Nishihira; M Kasai
Journal:  Tohoku J Exp Med       Date:  1983-04       Impact factor: 1.848

5.  Increase of beta 1-6-branched oligosaccharides in human esophageal carcinomas invasive against surrounding tissue in vivo and in vitro.

Authors:  R Takano; M Nose; T Nishihira; M Kyogoku
Journal:  Am J Pathol       Date:  1990-11       Impact factor: 4.307

6.  Amplification of epidermal growth factor receptor gene but no evidence of ras mutations in primary human esophageal cancers.

Authors:  M C Hollstein; A M Smits; C Galiana; H Yamasaki; J L Bos; A Mandard; C Partensky; R Montesano
Journal:  Cancer Res       Date:  1988-09-15       Impact factor: 12.701

7.  Growth-inhibitory effects of epidermal growth factor and overexpression of its receptors on human squamous cell carcinomas in culture.

Authors:  N Kamata; K Chida; K Rikimaru; M Horikoshi; S Enomoto; T Kuroki
Journal:  Cancer Res       Date:  1986-04       Impact factor: 12.701

8.  Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer.

Authors:  W P Bennett; M C Hollstein; A He; S M Zhu; J H Resau; B F Trump; R A Metcalf; J A Welsh; C Midgley; D P Lane
Journal:  Oncogene       Date:  1991-10       Impact factor: 9.867

9.  Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo.

Authors:  J Yokota; T Yamamoto; K Toyoshima; M Terada; T Sugimura; H Battifora; M J Cline
Journal:  Lancet       Date:  1986-04-05       Impact factor: 79.321

Review 10.  Studies on esophageal cancer cells in vitro.

Authors:  Q Q Pan
Journal:  Proc Chin Acad Med Sci Peking Union Med Coll       Date:  1989
View more
  66 in total

1.  The expression and role of Aquaporin 5 in esophageal squamous cell carcinoma.

Authors:  Hiroki Shimizu; Atsushi Shiozaki; Daisuke Ichikawa; Hitoshi Fujiwara; Hirotaka Konishi; Hiromichi Ishii; Shuhei Komatsu; Takeshi Kubota; Kazuma Okamoto; Mitsuo Kishimoto; Eigo Otsuji
Journal:  J Gastroenterol       Date:  2013-05-09       Impact factor: 7.527

2.  Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants.

Authors:  R C Fitzgerald; B A Onwuegbusi; M Bajaj-Elliott; I T Saeed; W R Burnham; M J G Farthing
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

3.  Novel 5-fluorouracil-resistant human esophageal squamous cell carcinoma cells with dihydropyrimidine dehydrogenase overexpression.

Authors:  Osamu Kikuchi; Shinya Ohashi; Yukie Nakai; Shunsaku Nakagawa; Kazuaki Matsuoka; Takashi Kobunai; Teiji Takechi; Yusuke Amanuma; Masahiro Yoshioka; Tomomi Ida; Yoshihiro Yamamoto; Yasushi Okuno; Shin'ichi Miyamoto; Hiroshi Nakagawa; Kazuo Matsubara; Tsutomu Chiba; Manabu Muto
Journal:  Am J Cancer Res       Date:  2015-07-15       Impact factor: 6.166

4.  SILAC-based quantitative proteomic approach to identify potential biomarkers from the esophageal squamous cell carcinoma secretome.

Authors:  Manoj Kumar Kashyap; H C Harsha; Santosh Renuse; Harsh Pawar; Nandini A Sahasrabuddhe; Min-Sik Kim; Arivusudar Marimuthu; Shivakumar Keerthikumar; Babylakshmi Muthusamy; Kumaran Kandasamy; Yashwanth Subbannayya; Thottethodi Subrahmanya Keshava Prasad; Riaz Mahmood; Raghothama Chaerkady; Stephen J Meltzer; Rekha V Kumar; Anil K Rustgi; Akhilesh Pandey
Journal:  Cancer Biol Ther       Date:  2010-10-15       Impact factor: 4.742

5.  Loss of transcription factor KLF5 in the context of p53 ablation drives invasive progression of human squamous cell cancer.

Authors:  Yizeng Yang; Hiroshi Nakagawa; Marie-Pier Tetreault; Janelle Billig; Noel Victor; Abha Goyal; Antonia R Sepulveda; Jonathan P Katz
Journal:  Cancer Res       Date:  2011-08-25       Impact factor: 12.701

Review 6.  Adjuvant therapies for cancer of the thoracic esophagus.

Authors:  T Nishihira; T Nakano; S Mori
Journal:  World J Surg       Date:  1994 May-Jun       Impact factor: 3.352

7.  Transcriptional regulation of thymine DNA glycosylase (TDG) by the tumor suppressor protein p53.

Authors:  Nathalia Meireles da Costa; Agnès Hautefeuille; Marie-Pierre Cros; Matias Eliseo Melendez; Timothy Waters; Peter Swann; Pierre Hainaut; Luis Felipe Ribeiro Pinto
Journal:  Cell Cycle       Date:  2012-11-19       Impact factor: 4.534

8.  Inflammatory gradient in Barrett's oesophagus: implications for disease complications.

Authors:  R C Fitzgerald; S Abdalla; B A Onwuegbusi; P Sirieix; I T Saeed; W R Burnham; M J G Farthing
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

9.  MicroRNA-34b has an oncogenic role in esophageal squamous cell carcinoma.

Authors:  Koshiro Harata; Hideyuki Ishiguro; Yoshiyuki Kuwabara; Masahiro Kimura; Akira Mitsui; Ryo Ogawa; Takeyasu Katada; Tatsuya Tanaka; Midori Shiozaki; Yoshitaka Fujii
Journal:  Oncol Lett       Date:  2010-07-01       Impact factor: 2.967

10.  xCT, component of cysteine/glutamate transporter, as an independent prognostic factor in human esophageal squamous cell carcinoma.

Authors:  Atsushi Shiozaki; Daisuke Iitaka; Daisuke Ichikawa; Shingo Nakashima; Hitoshi Fujiwara; Kazuma Okamoto; Takeshi Kubota; Shuhei Komatsu; Toshiyuki Kosuga; Hiroki Takeshita; Hiroki Shimizu; Yoshito Nako; Hisami Sasagawa; Mitsuo Kishimoto; Eigo Otsuji
Journal:  J Gastroenterol       Date:  2013-06-17       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.